Inactive Instrument

Company Stemcell Holdings, Inc. Other OTC

Equities

STMM

US85858N2027

Pharmaceuticals

Business Summary

Stemcell Holdings, Inc. is engaged in the regenerative medicine-related business, which provides technical assistance to the culturing, storing and delivery of stem cells, administrative and consulting services to clinics. The Company provides two options for stem cell regenerative therapy: autologous adipose derived mesenchymal stem cells (ADMSC) and natural killer cells (NK). The Company provides coordination services to facilitate its stem cell culturing business. Its coordination services include the introduction of patients to clinics, arranging patients’ schedules, and translating between patients and clinics. The Company offers Internet marketing services by providing search engine optimization for clinics. It also offers property and equipment rental services. The Company operates through its wholly owned subsidiary, Stemcell Co., Ltd.

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 427,378,000 423,104,220 ( 99.00 %) 0 99.00 %

Company contact information

Stemcell Holdings, Inc.

5-9-15-3F, Minamiaoyama Minato-ku

107-0062, Tokyo

+81 3 3400 0077

http://www.stemcell-holdings.com
address Stemcell Holdings, Inc.(STMM)

Group companies

NameCategory and Sector
Miscellaneous Commercial Services
  1. Stock Market
  2. Equities
  3. STMM Stock
  4. STMM Stock
  5. Company Stemcell Holdings, Inc.